Durability of Heterologous and Homologous COVID-19 Vaccine Boosts

IMPORTANCE: Antibody responses elicited by current messenger RNA (mRNA) COVID-19 vaccines decline rapidly and require repeated boosting. OBJECTIVE: To evaluate the immunogenicity and durability of heterologous and homologous prime-boost regimens involving the adenovirus vector vaccine Ad26.COV2.S an...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, C. Sabrina, Collier, Ai-ris Y., Yu, Jingyou, Liu, Jinyan, Chandrashekar, Abishek, McMahan, Katherine, Jacob-Dolan, Catherine, He, Xuan, Roy, Vicky, Hauser, Blake M., Munt, Jennifer E., Mallory, Michael L., Mattocks, Melissa, Powers, John M., Meganck, Rita M., Rowe, Marjorie, Hemond, Rachel, Bondzie, Esther A., Jaegle, Kate H., Baric, Ralph S., Schmidt, Aaron G., Alter, Galit, Le Gars, Mathieu, Sadoff, Jerald, Barouch, Dan H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9366542/
https://www.ncbi.nlm.nih.gov/pubmed/35947380
http://dx.doi.org/10.1001/jamanetworkopen.2022.26335

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9366542/
https://www.ncbi.nlm.nih.gov/pubmed/35947380
http://dx.doi.org/10.1001/jamanetworkopen.2022.26335

Ejemplares similares